| Title |
Naujoji specifinė migrenos profilaktika: monokloniniai antikūnai prieš CGRP ir jo receptorių / |
| Translation of Title |
New specific migraine prevention: monoclonal antibodies against calcitonin gene-related peptide and its recepto. |
| Authors |
Ryliškienė, Kristina ; Jatužis, Dalius ; Vaitkus, Antanas |
| DOI |
10.29014/ns.2019.24 |
| Full Text |
|
| Is Part of |
Neurologijos seminarai.. Vilnius : Rotas. 2019, t. 23, Nr. 4, p. 187-195.. ISSN 1392-3064. eISSN 2424-5917 |
| Keywords [eng] |
migraine ; economic burden ; prevention ; CGRP ; CGRP receptor ; monoclonal antibodies |
| Abstract [eng] |
Migraine is a long-lasting neurological disorder with significant negative impact not only on the patient’s life, but also on society. For many years, preventive treatment of migraine included drugs developed for diseases other than migraine such as hypertension, depression, and epilepsy. During the last decade, blocking calcitonin gene-related peptide (CGRP) has emerged as a possible mechanism for preventing migraine attacks, and monoclonal antibodies against CGRP and its receptor for the specific migraine prophylaxis have been developed. Results of clinical trials, safety and tolerability of the new class of drugs as well as guidelines for their use for the prevention of migraine are presented in this review article. |
| Published |
Vilnius : Rotas |
| Type |
Journal article |
| Language |
Lithuanian |
| Publication date |
2019 |
| CC license |
|
